LATS2 and esophageal squamous cell carcinoma: In esophageal squamous cell carcinoma, miR-31 was upregulated in clinical specimens and acted as an oncogenic miRNA by targeting the tumor suppressor gene LATS2, which is involved in the Hippo pathway [21].